Physician profile
Vinod Dasa
NPI 1215139431
$1,880,614.12
in general payments reported to CMS, 2019-2025
50 companies · $408K in 2025
The $408K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $317K · 2020: $150K · 2021: $157K · 2022: $280K · 2023: $287K · 2024: $282K · 2025: $408K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $461K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $271K · Honoraria: $139K · Travel and Lodging: $90K · Food and Beverage: $17K · Education: $6.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $461,432.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $270,638.75 |
| Honoraria | $138,683.39 |
| Travel and Lodging | $89,754.20 |
| Food and Beverage | $16,860.62 |
| Education | $6.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $943,503.76 | 2019-2025 | Iovera, Exparel, Zilretta |
| Bioventus LLC | $572,623.46 | 2019-2025 | Durolane, Durolane, Stimrouter Implantable Kit |
| Vertex Pharmaceuticals Incorporated | $149,127.71 | 2023-2025 | |
| Smith+Nephew, INC. | $76,473.55 | 2024-2025 | The Pink Hip Kit - Smith & Nephew Table, Double Endobutton, Healicoil |
| Stryker Corporation | $31,923.23 | 2019-2025 | Mako, Triathlon, Insignia |
| Sanara Medtech INC. | $27,056.04 | 2021-2024 | Celleraterx |
| Curonix LLC | $21,150.00 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Myoscience INC. | $20,206.41 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10,220.51 | 2020-2025 | |
| Teleflex LLC | $7,443.48 | 2023-2025 | Arrow |
| Pacira Cryotech Incorporated | $5,099.39 | 2019 | |
| Anika Therapeutics, INC. | $4,594.63 | 2022-2025 | Tactoset, Integrity Implant, Wristmotion |
| Ferring Pharmaceuticals INC. | $3,630.26 | 2019-2023 | Euflexxa |
| Acelrx Pharmaceuticals, INC. | $2,000.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $923.88 | 2019-2025 | Gps III Platelet Concentration System, Tapestry, Persona |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $751.30 | 2023-2024 | |
| Motive Health, INC. | $669.83 | 2020-2023 | |
| Arbutus Medical, INC | $550.00 | 2025 | |
| Maxx Orthopedics, INC. | $336.97 | 2021-2023 | |
| Medacta USA, INC. | $227.64 | 2022-2025 | Gmk Sphere |
| Heron Therapeutics, INC. | $180.40 | 2021-2024 | Zynrelef, Aponvie |
| Edwards Lifesciences Corporation | $156.46 | 2022 | |
| Conformis, INC. | $144.08 | 2022 | |
| Think Surgical, INC. | $140.30 | 2023 | |
| Cartiheal (2009) Ltd. | $138.83 | 2023 | Agili-C |
| Pacira Therapeutics, INC. | $128.26 | 2019-2020 | |
| Baudax Bio INC. | $122.35 | 2020-2021 | |
| Lilly USA, LLC | $121.83 | 2024 | Zepbound |
| Innocoll Pharmaceuticals Limited | $119.45 | 2022 | |
| Davol INC. | $116.31 | 2022 | |
| Next Science LLC | $110.20 | 2025 | Blastx, Xperience |
| Stimwave Technologies Incorporated | $103.27 | 2019 | |
| Restor3d, INC. | $102.05 | 2023 | |
| Spr Therapeutics, INC | $76.28 | 2024-2025 | Sprint Pns System |
| Fidia Pharma USA INC. | $59.73 | 2024-2025 | Triluron, Hymovis, Hyalgan |
| Acera Surgical, INC. | $38.34 | 2025 | Restrata Wound Matrix |
| Nalu Medical, INC. | $33.96 | 2024 | Nalu Neurostimulation System |
| Organogenesis INC. | $32.74 | 2023 | Puraply |
| Brainlab, INC. | $20.60 | 2022 | |
| Bsn Medical INC | $19.99 | 2019 | |
| Convatec INC. | $18.14 | 2019 | |
| Avanos Medical | $16.95 | 2023 | Trivisc Sodium Hyaluronate |
| Heraeus Medical, LLC. | $16.08 | 2025 | |
| Kci USA, INC. | $15.29 | 2020 | |
| Integra Lifesciences Corporation | $14.80 | 2019 | |
| Saluda Medical Americas, INC. | $14.79 | 2025 | Evoke |
| Vericel Corporation | $13.87 | 2019 | |
| Ucb, INC. | $13.54 | 2022 | |
| Pfizer INC. | $13.18 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$19,720.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Dasa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.